Log In
BCIQ
Print this Print this
 

Rizaport, rizatriptan (RHB-103)

  Manage Alerts
Collapse Summary General Information
Company IntelGenx Corp.
DescriptionFast-dissolving thin-film formulation of rizatriptan delivered using IntelGenx's VersaFilm oral disintegrating film
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentApproved
Standard IndicationMigraine
Indication DetailsTreat acute migraine; Treat migraines
Regulatory Designation U.S. - Standard Review (Treat acute migraine)
PartnerJuste S.A.Q.F.;
RedHill Biopharma Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$21.0M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/03/2010

$21.0M

Undisclosed

Undisclosed

Get a free BioCentury trial today